NIT1
Basic information
Region (hg38): 1:161118086-161125445
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NIT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 15 | 15 | ||||
Total | 0 | 1 | 51 | 1 | 0 |
Variants in NIT1
This is a list of pathogenic ClinVar variants found in the NIT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-161118850-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
1-161118856-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
1-161118865-C-T | not specified | Uncertain significance (Jun 08, 2022) | ||
1-161118878-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
1-161119138-A-G | not specified | Uncertain significance (Dec 03, 2024) | ||
1-161119146-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
1-161119168-G-A | not specified | Likely benign (Aug 20, 2024) | ||
1-161119186-G-A | not specified | Uncertain significance (Dec 31, 2024) | ||
1-161119189-T-A | not specified | Uncertain significance (Feb 14, 2023) | ||
1-161119238-C-T | not specified | Uncertain significance (Feb 28, 2025) | ||
1-161119250-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
1-161119253-A-G | not specified | Uncertain significance (Jul 30, 2024) | ||
1-161119255-G-C | not specified | Uncertain significance (May 26, 2022) | ||
1-161119271-C-G | not specified | Uncertain significance (Oct 20, 2024) | ||
1-161119328-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
1-161119384-G-A | not specified | Uncertain significance (May 10, 2024) | ||
1-161119519-C-T | not specified | Uncertain significance (Mar 06, 2025) | ||
1-161119861-T-G | not specified | Uncertain significance (Dec 27, 2023) | ||
1-161119869-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
1-161119890-G-C | not specified | Uncertain significance (Apr 08, 2023) | ||
1-161119897-A-G | not specified | Uncertain significance (Apr 04, 2024) | ||
1-161119900-C-T | not specified | Uncertain significance (Jul 10, 2024) | ||
1-161119909-C-T | not specified | Uncertain significance (May 17, 2023) | ||
1-161119954-T-G | Susceptibility to severe COVID-19 | Likely pathogenic (Jul 22, 2024) | ||
1-161120113-C-A | not specified | Uncertain significance (May 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NIT1 | protein_coding | protein_coding | ENST00000368009 | 7 | 7360 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.94e-7 | 0.770 | 125648 | 0 | 100 | 125748 | 0.000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.598 | 217 | 194 | 1.12 | 0.0000107 | 2086 |
Missense in Polyphen | 57 | 57.244 | 0.99574 | 573 | ||
Synonymous | -0.426 | 76 | 71.4 | 1.06 | 0.00000346 | 712 |
Loss of Function | 1.30 | 12 | 17.9 | 0.670 | 0.00000106 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00105 | 0.00105 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000450 | 0.000448 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000327 | 0.000327 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of the amide bond in N-(4- oxoglutarate)-L-cysteinylglycine (deaminated glutathione), a metabolite repair reaction to dispose of the harmful deaminated glutathione. Plays a role in cell growth and apoptosis: loss of expression promotes cell growth, resistance to DNA damage stress and increased incidence to NMBA-induced tumors. Has tumor suppressor properties that enhances the apoptotic responsiveness in cancer cells; this effect is additive to the tumor suppressor activity of FHIT. It is also a negative regulator of primary T- cells. {ECO:0000250|UniProtKB:Q8VDK1}.;
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.137
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.51
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- N
- hipred_score
- 0.196
- ghis
- 0.446
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.261
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nit1
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; neoplasm; normal phenotype;
Gene ontology
- Biological process
- nitrogen compound metabolic process;biological_process
- Cellular component
- nucleus;mitochondrion
- Molecular function
- nitrilase activity;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides